Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
Cardiovascular Diabetology|March 14, 2021
Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitusShuai Chen, Ying Shen, Yong-Hua Liu, et al.
Chinese Medical Journal|February 4, 2006
Prognosis of unprotected left main coronary artery stenting and the factors affecting the outcomes in ChineseRun-lin Gao, Bo Xu, Ji-lin Chen, et al.
Cardiovascular Diabetology|December 21, 2006
Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetesLi Jin Pu, Lin Lu, Xue Wei Xu, et al.
Chinese Medical Journal|April 20, 2007
Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical studyQi Zhang, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal|December 11, 2007
Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarctionQi Zhang, Jie Shen, Rui-yan Zhang, et al.
Chinese Medical Journal|March 28, 2008
Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stentBo Xu, Qi Zhang, Yue-jin Yang, et al.
Journal of the American College of Cardiology|October 14, 2017
Glycated Apolipoprotein A-IV Induces Atherogenesis in Patients With CAD in Type 2 DiabetesYang Dai, Ying Shen, Qing Run Li, et al.
International Journal of Cardiology|July 11, 2016
Association of decreased serum vasostatin-2 level with ischemic chronic heart failure and with MACE in 3-year follow-up: Vasostatin-2 prevents heart failure in myocardial infarction ratsWen Qi Pan, Yu Hu He, Qian Su, et al.
European Heart Journal|May 31, 2012
Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery diseaseLin Lu, Ya Nan Wang, Ming Chun Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 11, 2017
Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCsYu Hu He, Xiao Qun Wang, Jian Zhang, et al.
Pageof 20